Sub Cutaneous Insulin Infusion
Showing 1 - 25 of >10,000
Follicular Lymphoma Trial in France (Rituximab IV, Rituximab SC)
Completed
- Follicular Lymphoma
- Rituximab IV
- Rituximab SC
-
Aix En Provence, France
- +49 more
Jan 9, 2023
Obesity, Abdominal Trial in Aarhus (Placebo, Cafestol)
Active, not recruiting
- Obesity, Abdominal
- Placebo
- Cafestol
-
Aarhus, Aarhus N, DenmarkSteno Diabetes Center Aarhus
Jan 4, 2023
DKA Trial in Saint Paul (Insulin Glargine)
Recruiting
- DKA
- Insulin Glargine
-
Saint Paul, MinnesotaRegions Hospital
Aug 21, 2023
Lupus Erythematosus, Systemic, Lupus Erythematosus, Cutaneous Trial (Placebo, PF-06823859)
Not yet recruiting
- Lupus Erythematosus, Systemic
- Lupus Erythematosus, Cutaneous
- Placebo
- PF-06823859
- (no location specified)
May 18, 2023
Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease Trial in New York (drug, other, dietary supplement,
Not yet recruiting
- Insulin Resistance
- +3 more
- Insulin human
- +11 more
-
New York, New YorkColumbia University Irving Medical Center
Nov 6, 2023
Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease
Not yet recruiting
- Rheumatoid Arthritis
- +2 more
- collection of clinical parameters and blood sample
-
Paris, IDF, FranceRheumatology Department, Cochin Hospital
Jun 17, 2022
Insulin Sensitivity Trial in San Antonio (Glucagon Infusion, Saline)
Recruiting
- Insulin Sensitivity
- Glucagon Infusion
- Saline
-
San Antonio, Texas
- +1 more
Sep 8, 2022
Alzheimer, Mild Cognitive Impairment, Positron Emission Tomography Trial in Turku (FDG-PET study)
Recruiting
- Alzheimer Disease
- +2 more
- FDG-PET study
-
Turku, FinlandTurku PET Centre
Oct 30, 2023
Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Orlando (Exercise Test)
Not yet recruiting
- Cutaneous Melanoma
- +2 more
- Exercise Test
-
Orlando, FloridaAdventHealth Translational Research Institute
Aug 18, 2023
Total Intravenous Anesthesia, Inhalational Anesthesia, Surgical Stress Response Trial in Assiut (Target Controlled Infusion,
Not yet recruiting
- Total Intravenous Anesthesia
- +3 more
- Target Controlled Infusion
- +2 more
-
Assiut, EgyptAssiut University
Aug 29, 2023
Type 1 Diabetes Trial in Montreal (device, drug, other)
Completed
- Type 1 Diabetes
- Single-hormone closed-loop system
- +9 more
-
Montreal, Quebec, Canada
- +1 more
Jan 13, 2022
Ketamine Infusion, Complex Regional Pain Syndromes Trial in Tanta (Ketamine)
Not yet recruiting
- Ketamine Infusion
- Complex Regional Pain Syndromes
-
Tanta, El-garbia, EgyptTanta University
Aug 10, 2023
Pompe Disease Trial in Worldwide (alglucosidase alfa)
Completed
- Pompe Disease
- alglucosidase alfa
-
Phoenix, Arizona
- +17 more
Jul 12, 2021
Dexcom Hybrid Closed Loop Insulin Pump Study in Type 1 Diabetes
Not yet recruiting
- Type 1 Diabetes Mellitus
- Tandem Control IQ Hybrid Closed Loop Insulin Delivery System
- (no location specified)
Apr 11, 2022
Diabetes, Critical Illness, Hyperglycemia Trial in Riyadh (Degludec insulin)
Recruiting
- Diabetes Mellitus
- +2 more
- Degludec insulin
-
Riyadh, Saudi ArabiaKing Faisal Specialist Hospital & Research Centre
Sep 24, 2023
Insulin Resistance, Prediabetic State, Hyperinsulinemia Trial in New York (drug, other, dietary supplement, device)
Recruiting
- Insulin Resistance
- +4 more
- Insulin human
- +8 more
-
New York, New YorkColumbia University Irving Medical Center
Feb 2, 2023
Type 1 Diabetes Trial in Portland, Seattle, Spokane (MPC closed-loop system, t:slim X2 pump with Dexcom G6 CGM and Control IQ)
Recruiting
- Type 1 Diabetes
- MPC closed-loop system
- t:slim X2 pump with Dexcom G6 CGM and Control IQ
-
Portland, Oregon
- +2 more
Mar 23, 2023
Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Bortezomib)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Sep 7, 2023
Hypertriglyceridemia, Acute Pancreatitis Trial (insulin, standard treatment)
Not yet recruiting
- Hypertriglyceridemia
- Acute Pancreatitis
- insulin
- standard treatment
- (no location specified)
Aug 3, 2022
Acute Coronary Syndrome, Type 2 Diabetes Trial in Paris (Control Glucose Monitoring System)
Not yet recruiting
- Acute Coronary Syndrome
- Type 2 Diabetes
- Control Glucose Monitoring System
-
Paris, ILE De France, FranceBichat Hospital
Nov 22, 2021
Type II Diabetes, Gestational Diabetes Trial in Danville, Wilkes-Barre (Rotating fluids protocol, Insulin infusion protocol)
Recruiting
- Type II Diabetes Mellitus
- Gestational Diabetes Mellitus
- Rotating fluids protocol
- Insulin infusion protocol
-
Danville, Pennsylvania
- +1 more
Nov 12, 2021
Cardiovascular Diseases, Cardiovascular Risk Factor, Vasoconstriction Trial in Arlington (BQ-788, BQ-123, L-Arginine)
Recruiting
- Cardiovascular Diseases
- +2 more
- BQ-788
- +5 more
-
Arlington, TexasScience and Engineering Research and Innovation Building
Feb 7, 2022
Anesthesia, Local, Knee Arthropathy Trial in Alexandria (Triple Injection Perisartorius block, Dual sub sartorial block, Femoral
Not yet recruiting
- Anesthesia, Local
- Knee Arthropathy
- Triple Injection Perisartorius block
- +4 more
-
Alexandria, EgyptAlexandria Faculty of Medicine
Oct 25, 2023
Ventricular Arrhythmia Trial in Canada (Implantable Cardioverter Defibrillator)
Completed
- Ventricular Arrhythmia
- Implantable Cardioverter Defibrillator
-
Calgary, Alberta, Canada
- +13 more
May 26, 2022
Diabetes, Type I Trial in Padova (Simulation of an insulin pump failure)
Not yet recruiting
- Diabetes Mellitus, Type I
- Simulation of an insulin pump failure
-
Padova, PD, ItalyAzienda Ospedaliera di Padova
Nov 22, 2023